Insurance - Life
Compare Stocks
5 / 10Stock Comparison
ABLLL vs ABL vs HIFS vs CSWC vs PFLT
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Life
Banks - Regional
Asset Management
Asset Management
ABLLL vs ABL vs HIFS vs CSWC vs PFLT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Life | Insurance - Life | Banks - Regional | Asset Management | Asset Management |
| Market Cap | $2.50B | $791M | $626M | $1.43B | $888M |
| Revenue (TTM) | $197M | $0.00 | $217M | $164M | $172M |
| Net Income (TTM) | $11M | $37M | $45M | $103M | $118M |
| Gross Margin | 87.5% | — | 30.1% | 66.5% | 45.6% |
| Operating Margin | 25.0% | — | 16.8% | 48.5% | 39.4% |
| Forward P/E | 25.7x | 8.1x | 20.4x | 10.1x | 7.9x |
| Total Debt | $386M | $0.00 | $1.50B | $956M | $1.78B |
| Cash & Equiv. | $132M | $-385K | $352M | $43M | $123M |
ABLLL vs ABL vs HIFS vs CSWC vs PFLT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | Mar 26 | Return |
|---|---|---|---|
| Abacus Life, Inc. 9… (ABLLL) | 100 | 103.8 | +3.8% |
| Abacus Global Manag… (ABL) | 100 | 132.3 | +32.3% |
| Hingham Institution… (HIFS) | 100 | 171.2 | +71.2% |
| Capital Southwest C… (CSWC) | 100 | 97.1 | -2.9% |
| PennantPark Floatin… (PFLT) | 100 | 73.2 | -26.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ABLLL vs ABL vs HIFS vs CSWC vs PFLT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ABLLL has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.03, Low D/E 91.2%, current ratio 2.55x
- 68.6% revenue growth vs ABL's -100.0%
- Beta 0.03 vs HIFS's 1.25, lower leverage
ABL is the clearest fit if your priority is valuation efficiency.
- PEG 0.12 vs PFLT's 0.89
- 5.6% ROA vs HIFS's 1.0%, ROIC 52.3% vs 1.4%
HIFS is the clearest fit if your priority is growth exposure.
- Rev growth 14.1%, EPS growth 6.8%
CSWC is the #2 pick in this set and the best alternative if long-term compounding and bank quality is your priority.
- 234.2% 10Y total return vs HIFS's 142.5%
- NIM 7.0% vs HIFS's 1.0%
- 43.1% margin vs ABLLL's 5.6%
- +34.0% vs ABL's +0.5%
PFLT ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 3 yrs, beta 0.79, yield 13.5%
- Beta 0.79, yield 13.5%, current ratio 2.94x
- Lower P/E (7.9x vs 10.1x)
- 13.5% yield, 3-year raise streak, vs HIFS's 0.9%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 68.6% revenue growth vs ABL's -100.0% | |
| Value | Lower P/E (7.9x vs 10.1x) | |
| Quality / Margins | 43.1% margin vs ABLLL's 5.6% | |
| Stability / Safety | Beta 0.03 vs HIFS's 1.25, lower leverage | |
| Dividends | 13.5% yield, 3-year raise streak, vs HIFS's 0.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +34.0% vs ABL's +0.5% | |
| Efficiency (ROA) | 5.6% ROA vs HIFS's 1.0%, ROIC 52.3% vs 1.4% |
ABLLL vs ABL vs HIFS vs CSWC vs PFLT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
ABLLL vs ABL vs HIFS vs CSWC vs PFLT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PFLT leads in 2 of 6 categories
ABL leads 1 • CSWC leads 1 • ABLLL leads 0 • HIFS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ABLLL and CSWC and PFLT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HIFS and ABL operate at a comparable scale, with $217M and $0 in trailing revenue. CSWC is the more profitable business, keeping 43.1% of every revenue dollar as net income compared to ABLLL's 5.6%. On growth, ABLLL holds the edge at +123.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $197M | $0 | $217M | $164M | $172M |
| EBITDAEarnings before interest/tax | $66M | $107M | $62M | $142M | $39M |
| Net IncomeAfter-tax profit | $11M | $37M | $45M | $103M | $118M |
| Free Cash FlowCash after capex | -$111M | -$49M | $30M | -$69M | $242M |
| Gross MarginGross profit ÷ Revenue | +87.5% | — | +30.1% | +66.5% | +45.6% |
| Operating MarginEBIT ÷ Revenue | +25.0% | — | +16.8% | +48.5% | +39.4% |
| Net MarginNet income ÷ Revenue | +5.6% | — | +13.0% | +43.1% | +38.7% |
| FCF MarginFCF ÷ Revenue | -56.6% | — | +5.4% | -132.6% | +55.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +123.7% | -5.9% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +191.7% | +134.1% | +195.1% | +113.3% | +40.9% |
Valuation Metrics
PFLT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.4x trailing earnings, PFLT trades at a 44% valuation discount to HIFS's 22.3x P/E. Adjusting for growth (PEG ratio), ABL offers better value at 0.12x vs PFLT's 1.40x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.5B | $791M | $626M | $1.4B | $888M |
| Enterprise ValueMkt cap + debt − cash | $2.8B | $1.0B | $1.8B | $2.3B | $2.5B |
| Trailing P/EPrice ÷ TTM EPS | -75.31x | -23.79x | 22.33x | 16.32x | 12.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.66x | 8.11x | 20.43x | 10.06x | 7.93x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.12x | — | — | 1.40x |
| EV / EBITDAEnterprise value multiple | 392.45x | 148.79x | 47.53x | 27.43x | 37.66x |
| Price / SalesMarket cap ÷ Revenue | 22.35x | 7.07x | 2.88x | 8.71x | 5.18x |
| Price / BookPrice ÷ Book value/share | 4.28x | 1.35x | 1.46x | 1.39x | 0.77x |
| Price / FCFMarket cap ÷ FCF | — | — | 53.27x | — | 9.34x |
Profitability & Efficiency
ABL leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ABL delivers a 11.3% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $3 for ABLLL. ABLLL carries lower financial leverage with a 0.91x debt-to-equity ratio, signaling a more conservative balance sheet compared to HIFS's 3.47x. On the Piotroski fundamental quality scale (0–9), HIFS scores 5/9 vs CSWC's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.5% | +11.3% | +9.8% | +10.3% | +11.2% |
| ROA (TTM)Return on assets | +1.2% | +5.6% | +1.0% | +4.8% | +4.3% |
| ROICReturn on invested capital | -0.1% | +52.3% | +1.4% | +3.5% | +2.1% |
| ROCEReturn on capital employed | -0.2% | +22.0% | +2.2% | +4.6% | +2.7% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 2 | 5 | 1 | 4 |
| Debt / EquityFinancial leverage | 0.91x | — | 3.47x | 1.08x | 1.65x |
| Net DebtTotal debt minus cash | $254M | $384,618 | $1.1B | $913M | $1.7B |
| Cash & Equiv.Liquid assets | $132M | -$384,618 | $352M | $43M | $123M |
| Total DebtShort + long-term debt | $386M | $0 | $1.5B | $956M | $1.8B |
| Interest CoverageEBIT ÷ Interest expense | 1.74x | 3.98x | 0.44x | 2.91x | 0.35x |
Total Returns (Dividends Reinvested)
CSWC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSWC five years ago would be worth $15,138 today (with dividends reinvested), compared to $8,459 for ABL. Over the past 12 months, CSWC leads with a +34.0% total return vs ABL's +0.5%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs ABL's -7.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.4% | +2.1% | +6.3% | +11.4% | -0.4% |
| 1-Year ReturnPast 12 months | +12.5% | +0.5% | +14.4% | +34.0% | +1.5% |
| 3-Year ReturnCumulative with dividends | +25.1% | -19.5% | +61.9% | +75.8% | +18.2% |
| 5-Year ReturnCumulative with dividends | +25.1% | -15.4% | -1.9% | +51.4% | +17.2% |
| 10-Year ReturnCumulative with dividends | +25.1% | -14.6% | +142.5% | +234.2% | +72.6% |
| CAGR (3Y)Annualised 3-year return | +7.8% | -7.0% | +17.4% | +20.7% | +5.7% |
Risk & Volatility
Evenly matched — ABLLL and CSWC each lead in 1 of 2 comparable metrics.
Risk & Volatility
ABLLL is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than HIFS's 1.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs ABL's 77.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.03x | 1.11x | 1.25x | 0.84x | 0.79x |
| 52-Week HighHighest price in past year | $26.35 | $10.50 | $338.00 | $24.43 | $10.88 |
| 52-Week LowLowest price in past year | $20.52 | $4.60 | $220.76 | $19.37 | $7.68 |
| % of 52W HighCurrent price vs 52-week peak | +97.2% | +77.0% | +84.9% | +98.2% | +82.3% |
| RSI (14)Momentum oscillator 0–100 | 43.1 | 36.8 | 51.0 | 63.7 | 68.2 |
| Avg Volume (50D)Average daily shares traded | 5K | 641K | 51K | 664K | 987K |
Analyst Outlook
PFLT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ABL as "Buy", CSWC as "Buy", PFLT as "Buy". Consensus price targets imply 36.0% upside for ABL (target: $11) vs -6.2% for CSWC (target: $23). For income investors, PFLT offers the higher dividend yield at 13.47% vs HIFS's 0.87%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $11.00 | — | $22.50 | $10.50 |
| # AnalystsCovering analysts | — | 2 | — | 10 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.9% | +10.2% | +13.5% |
| Dividend StreakConsecutive years of raises | 3 | 0 | 0 | 3 | 3 |
| Dividend / ShareAnnual DPS | — | $0.00 | $2.50 | $2.45 | $1.21 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +1.4% | 0.0% | 0.0% | 0.0% |
PFLT leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). ABL leads in 1 (Profitability & Efficiency). 2 tied.
ABLLL vs ABL vs HIFS vs CSWC vs PFLT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ABLLL or ABL or HIFS or CSWC or PFLT a better buy right now?
For growth investors, Abacus Life, Inc.
9. 875% Fixed Rate Senior Notes due 2028 (ABLLL) is the stronger pick with 68. 6% revenue growth year-over-year, versus -100. 0% for Abacus Global Management, Inc. (ABL). PennantPark Floating Rate Capital Ltd. (PFLT) offers the better valuation at 12. 4x trailing P/E (7. 9x forward), making it the more compelling value choice. Analysts rate Abacus Global Management, Inc. (ABL) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ABLLL or ABL or HIFS or CSWC or PFLT?
On trailing P/E, PennantPark Floating Rate Capital Ltd.
(PFLT) is the cheapest at 12. 4x versus Hingham Institution for Savings at 22. 3x. On forward P/E, PennantPark Floating Rate Capital Ltd. is actually cheaper at 7. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Abacus Global Management, Inc. wins at 0. 12x versus PennantPark Floating Rate Capital Ltd. 's 0. 89x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ABLLL or ABL or HIFS or CSWC or PFLT?
Over the past 5 years, Capital Southwest Corporation (CSWC) delivered a total return of +51.
4%, compared to -15. 4% for Abacus Global Management, Inc. (ABL). Over 10 years, the gap is even starker: CSWC returned +234. 2% versus ABL's -14. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ABLLL or ABL or HIFS or CSWC or PFLT?
By beta (market sensitivity over 5 years), Abacus Life, Inc.
9. 875% Fixed Rate Senior Notes due 2028 (ABLLL) is the lower-risk stock at 0. 03β versus Hingham Institution for Savings's 1. 25β — meaning HIFS is approximately 3957% more volatile than ABLLL relative to the S&P 500. On balance sheet safety, Abacus Life, Inc. 9. 875% Fixed Rate Senior Notes due 2028 (ABLLL) carries a lower debt/equity ratio of 91% versus 3% for Hingham Institution for Savings — giving it more financial flexibility in a downturn.
05Which is growing faster — ABLLL or ABL or HIFS or CSWC or PFLT?
By revenue growth (latest reported year), Abacus Life, Inc.
9. 875% Fixed Rate Senior Notes due 2028 (ABLLL) is pulling ahead at 68. 6% versus -100. 0% for Abacus Global Management, Inc. (ABL). On earnings-per-share growth, the picture is similar: Abacus Global Management, Inc. grew EPS 211. 8% year-over-year, compared to -312. 5% for Abacus Life, Inc. 9. 875% Fixed Rate Senior Notes due 2028. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ABLLL or ABL or HIFS or CSWC or PFLT?
Capital Southwest Corporation (CSWC) is the more profitable company, earning 43.
1% net margin versus -21. 4% for Abacus Life, Inc. 9. 875% Fixed Rate Senior Notes due 2028 — meaning it keeps 43. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSWC leads at 48. 5% versus -0. 8% for ABLLL. At the gross margin level — before operating expenses — ABLLL leads at 89. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ABLLL or ABL or HIFS or CSWC or PFLT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Abacus Global Management, Inc. (ABL) is the more undervalued stock at a PEG of 0. 12x versus PennantPark Floating Rate Capital Ltd. 's 0. 89x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, PennantPark Floating Rate Capital Ltd. (PFLT) trades at 7. 9x forward P/E versus 25. 7x for Abacus Life, Inc. 9. 875% Fixed Rate Senior Notes due 2028 — 17. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ABL: 36. 0% to $11. 00.
08Which pays a better dividend — ABLLL or ABL or HIFS or CSWC or PFLT?
In this comparison, PFLT (13.
5% yield), CSWC (10. 2% yield), HIFS (0. 9% yield) pay a dividend. ABLLL, ABL do not pay a meaningful dividend and should not be held primarily for income.
09Is ABLLL or ABL or HIFS or CSWC or PFLT better for a retirement portfolio?
For long-horizon retirement investors, Abacus Life, Inc.
9. 875% Fixed Rate Senior Notes due 2028 (ABLLL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03)). Both have compounded well over 10 years (ABLLL: +25. 1%, ABL: -14. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ABLLL and ABL and HIFS and CSWC and PFLT?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ABLLL is a small-cap high-growth stock; ABL is a small-cap quality compounder stock; HIFS is a small-cap quality compounder stock; CSWC is a small-cap deep-value stock; PFLT is a small-cap deep-value stock. HIFS, CSWC, PFLT pay a dividend while ABLLL, ABL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.